Archives of Neurology

Journal

Publication Venue For

  • A trial of scheduled deep brain stimulation for tourette syndrome: Moving away from continuous deep brain stimulation paradigms.  70:85-94. 2013
  • Archetypal and new families with Alexander disease and novel mutations in GFAP.  69:208-214. 2012
  • Pontine ring-enhancing glioblastoma multiforme-like fungal abscess.  68:1476-1477. 2011
  • Association of low ejection fraction with impaired verbal memory in older patients with heart failure.  68:1021-1026. 2011
  • Rett Syndrome: Exploring the autism link.  68:985-989. 2011
  • Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis.  68:437-444. 2011
  • Targets of the peroxisome proliferator - activated receptor γ agonist trials for the prevention of Alzheimer disease: Reply.  68:542-543. 2011
  • A comprehensive genetic association study of Alzheimer disease in African Americans.  68:1569-1579. 2011
  • A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with alzheimer disease.  68:45-50. 2011
  • Disability progression in a clinical trial of relapsing-remitting multiple sclerosis eight-year follow-up.  67:1329-1335. 2010
  • Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative..  67:1370-1378. 2010
  • SNCA variant associated with Parkinson disease and plasma α-synuclein level.  67:1350-1356. 2010
  • A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma.  67:313-319. 2010
  • Malignant astrocytomas: A system disease.  67:353-355. 2010
  • Apparent widening gap in access to neuro-oncologic care in the United States: Need for action.  67:1137-1139. 2010
  • Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.  66:1366-1372. 2009
  • Disparate diseases due to copycat copy number variations.  66:1158-1159. 2009
  • Rhinocerebral mucormycosis in a 12-year-old girl.  66:272-273. 2009
  • Reproducibility of optical coherence tomography in multiple sclerosis.  65:1218-1222. 2008
  • Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.  65:924-928. 2008
  • Randomized controlled trial of ethyl-eicosapentaenoic acid in huntington disease.  65:1582-1589. 2008
  • Notice of redundant publication: "Transdermal rotigotine: Double-blind, placebo-controlled trial in Parkinson disease" (Arch Neurol. 2007;64[5]:676-682). In reply [3].  64:1801. 2007
  • Transdermal rotigotine: Double-blind, placebo-controlled trial in Parkinson disease.  64:676-682. 2007
  • Progranulin mutations in primary progressive aphasia: The PPA1 and PPA3 families.  64:43-47. 2007
  • Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.  63:1250-1254. 2006
  • Early-onset Alzheimer disease in families with late-onset alzheimer disease: A potential important subtype of familial Alzheimer disease.  63:1307-1311. 2006
  • Race/ethnicity, sex, and socioeconomic status as predictors of outcome after surgery for temporal lobe epilepsy.  63:1106-1110. 2006
  • At Risk for Huntington Disease.  63:991-991. 2006
  • Influence of heterozygosity for Parkin mutation on onset age in familial parkinson disease: The genePD study.  63:826-832. 2006
  • Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.  63:614-619. 2006
  • Analysis of the LRRK2 G2019S mutation in Alzheimer disease [3].  63:156-157. 2006
  • Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.  62:1833-1837. 2005
  • Microarrays: Applications and pitfalls.  62:1669-1672. 2005
  • Frontotemporal lobar degeneration: Demographic characteristics of 353 patients.  62:925-930. 2005
  • Monozygotic twins discordant for Huntington disease after 7 years.  62:995-997. 2005
  • Applications of laser capture microdissection in the study of neurodegenerative disease.  62:203-205. 2005
  • Genomic discovery reveals a molecular system for resistance to oxidative and endoplasmic reticulum stress in cultured glioma.  62:233-236. 2005
  • Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremor.  62:141-143. 2005
  • A novel polymerase γ mutation in a family with ophthalmoplegia, neuropathy, and parkinsonism.  61:1777-1779. 2004
  • Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.  61:1563-1568. 2004
  • Elevated plasma homocysteine level in patients with Parkinson disease: Motor, affective, and cognitive associations.  61:865-868. 2004
  • Multilevel Intramedullary Spinal Neurocysticercosis with Eosinophilic Meningitis.  61:770-772. 2004
  • Loss of Calculation Abilities in Patients with Mild and Moderate Alzheimer Disease.  60:1585-1589. 2003
  • Callosal neglect and cognitive impersistence..  60:1493-1494. 2003
  • Significance of fornix atrophy in temporal lobe epilepsy surgery outcome.  60:1238-1242. 2003
  • Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.  60:1100-1105. 2003
  • The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic [4].  60:1170-1173. 2003
  • Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.  60:975-980. 2003
  • Temporal lobectomy in congenital porencephaly associated with hippocampal sclerosis.  60:830-834. 2003
  • Depression as a risk factor for Alzheimer disease: The MIRAGE Study.  60:753-759. 2003
  • A controlled trial of rasagiline in early Parkinson disease: The tempo study.  59:1937-1943. 2002
  • In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy.  59:1882-1886. 2002
  • Risk to verbal memory following anterior temporal lobectomy in patients with severe left-sided hippocampal sclerosis.  59:1895-1901. 2002
  • Effects of coenzyme Q 10 in early Parkinson disease: Evidence of slowing of the functional decline.  59:1541-1550. 2002
  • Familial aggregation of Parkinson disease: A comparative study of early-onset and late-onset disease.  59:848-850. 2002
  • A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy.  59:217-222. 2002
  • Association between apolipoprotein E genotype and Alzheimer disease in African American subjects.  59:594-600. 2002
  • Current immunotherapy for demyelinating diseases.  59:726-731. 2002
  • Darts in the dark cure animal, but not human, brain tumors.  59:721-724. 2002
  • Independent predictors of cognitive decline in healthy elderly persons.  59:601-606. 2002
  • Complications of gamma knife surgery for Parkinson disease.  58:1995-2002. 2001
  • Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia.  58:383-387. 2001
  • Magnetic resonance spectroscopic imaging in temporal lobe epilepsy.  58:2048-2053. 2001
  • Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: Neuronal dysfunction or cell loss?.  58:2048-2053. 2001
  • Open-label, multicenter, phase 3, extension study of the safety and efficacy of donepezil in patients with Alzheimer disease.  58:427-433. 2001
  • Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis.  58:49-54. 2001
  • Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.  58:961-967. 2001
  • Clinical significance of the multiple sclerosis functional composite: Relationship to patient-reported quality of life.  57:1319-1324. 2000
  • Assessing financial capacity in patients with Alzheimer disease: A conceptual model and prototype instrument.  57:877-884. 2000
  • Fiction, reality, and molecular neurology.  57:63-64. 2000
  • Urinary myelin basic protein-like material in patients with multiple sclerosis during interferon beta-1b treatment.  56:687-691. 1999
  • Paraneoplastic neurological syndromes: Paraneoplastic or neurological?.  56:151-152. 1999
  • Developmental deficits in adult patients with arteriovenous malformations.  56:103-106. 1999
  • New molecular strategies to cure brain tumors.  56:449-453. 1999
  • Hemianopsia in dementia with Lewy bodies.  55:1132-1135. 1998
  • Brain tumors in the elderly: Undefeated and gaining ground.  55:905-906. 1998
  • Pendular nystagmus in patients with peroxisomal assembly disorder.  55:554-558. 1998
  • 'Complicated' autosomal dominant familial spastic paraplegia is genetically distinct from 'pure' forms.  54:379-384. 1997
  • The delay in reporting symptoms of carotid artery stenosis in an at- risk population the asymptomatic carotid atherosclerosis study experience: A statement of concern regarding watchful waiting.  54:1267-1271. 1997
  • Decision-Making Capacity-Reply.  53:589-590. 1996
  • Assessing the Competency of Patients with Alzheimer's Disease Under Different Legal Standards: A Prototype Instrument.  52:949-954. 1995
  • Cerebrospinal Fluid Treponemal Antibodies in Untreated Early Syphilis.  52:68-72. 1995
  • Neglect and hemianopia.  52:651-652. 1995
  • Neuropsychologic Predictors of Competency in Alzheimer's Disease using a Rational Reasons Legal Standard.  52:955-959. 1995
  • Choreoathetosis/Ballismus Associated with Pentamidine-Induced Hypoglycemia in a Patient with the Acquired Immunodeficiency Syndrome.  51:723-725. 1994
  • Reliability and Validity of Nincds-Adrda Criteria for Alzheimer's Disease: The National Institute of Mental Health Genetics Initiative.  51:1198-1204. 1994
  • Subacute Inflammatory Demyelinating Polyneuropathy: Not a New Concept.  51:234-235. 1994
  • Predictive Value of Magnetic Resonance Imaging in Temporal Lobe Epilepsy Surgery.  50:65-69. 1993
  • Distinct syndromes of hemineglect.  49:1187-1194. 1992
  • Factors Associated With Slow Progression in Huntington's Disease.  48:800-804. 1991
  • The Relationship of High-Intensity Signals on Magnetic Resonance Images to Cognitive and Psychiatric State in Alzheimer's Disease.  48:1136-1140. 1991
  • Long-Term Cognitive Sequelae of Acyclovir-Treated Herpes Simplex Encephalitis.  47:646-647. 1990
  • Morphometric Studies in Dominant Olivopontocerebellar Atrophy: Comparison of Cell Losses With Amino Acid Decreases.  47:188-192. 1990
  • On Cerebral Metabolism and Aphasia.  46:1271-1272. 1989
  • Rett's Syndrome: Correlation of Electroencephalographic Characteristics With Clinical Staging.  44:1053-1056. 1987
  • Yes, Brain Biopsy Should Be a Prerequisite for Herpes Simplex Encephalitis Treatment.  44:1289-1290. 1987
  • Physicians' Attitudes: Management of Carotid Artery Plaques, Murmurs, and Transient Ischemic Attacks.  42:1198-1201. 1985
  • Oculosympathetic Spasm With Cervical Spinal Cord Injury.  41:61-64. 1984
  • Nonprogressive Congenital Neuromuscular Disease With Uniform Type 1 Fiber.  40:147-150. 1983
  • Extracranial Carotid Artery Arteriosclerosis: Diagnosis With Continuous-Wave Doppler and Real-time Ultrasound Studies.  39:393-394. 1982
  • Lymphomatoid Granulomatosis Manifested as a Mass in the Cerebellopontine Angle.  39:319-320. 1982
  • Nonbacterial Thrombotic Endocarditis: A Neurologic Perspective of Clinicopathologic Correlations of 99 Patients.  39:95-98. 1982
  • Optic Neuritis and Myelitis Following Rubella Vaccination.  39:443-444. 1982
  • Pseudo-Horner's Syndrome.  39:108-111. 1982
  • Physician Attitudes: Management of Asymptomatic Carotid Artery Murmur and Transient Ischemic Attacks.  38:443-446. 1981
  • Echocardiographic Evaluation of Cardiac Abnormalities in Duchenne's Dystrophy and Myotonic Muscular Dystrophy.  37:273-277. 1980
  • Subacute Demyelinating Polyneuropathy Responding to Corticosteroid Treatment.  35:509-516. 1978
  • Giant Axonal Swelling in “Huffer's” Neuropathy.  33:583-586. 1976
  • Hemangioblastoma of the Spinal Cord: Review and Report of Five Cases.  33:435-441. 1976
  • Cerebral Blood Flow: A Predictor of Recovery From Ischemia in the Gerbil.  32:457-461. 1975
  • The Eaton-Lambert Syndrome in Ocular Myasthenia Gravis.  31:183-186. 1974
  • Ultrastructure Manifestations of GM1 and GM2 Gangliosidosis in Fetal Tissues.  28:417-419. 1973
  • Chronic Decerebrate State in Infancy: Neurologic Observations in Long Surviving Cases of Hydranencephaly.  19:339-346. 1968
  • International Standard Serial Number (issn)

  • 0003-9942
  • Electronic International Standard Serial Number (eissn)

  • 1538-3687